“type-2-diabetes” Archives

in
Entry Author Date Location
With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells 06/21/17 Boston
With Gene Therapy for Diabetes, San Antonio Researcher Eyes Funding 05/31/17 Texas
Future At Stake, Zafgen Gives First Glimpse of New Obesity Drug Data 05/04/17 Boston
Some See Large EHR Vendors as Playing Catch-up in Population Health 05/03/17 Wisconsin
ViaCyte Working with Gore to Improve its Synthetic Pancreas Device 03/29/17 San Diego
Backed by $37M, Virta Tries Tech Approach to “Reverse” Diabetes 03/08/17 San Francisco
Gates Foundation Sends $140M to Intarcia for HIV Version of Pump 12/29/16 Boston
Diabetes Study, Hiring News, Growth Mileposts, & More Local Tech News 12/27/16 Indiana
Sanofi, Verily Fund Diabetes Startup With $500M 09/12/16 Boston
After Shift to Duchenne and Cholesterol Drugs, Catabasis Files For IPO 05/14/15 Boston
Intarcia, Still Private, Nabs $225M More For Diabetes Device 04/28/15 Boston
Xbiotech’s $76M Offering Sets Course for Late-Stage Cancer Studies 04/15/15 Texas
Gelesis Bags $22M More, Ramps Up Trials for Weight-Loss Pill 03/26/15 Boston
With Narrowed Focus, Elcelyx Prepares for Diabetes Drug Trial 03/05/15 San Diego
Rethinking Venture Philanthropy After the Kalydeco Windfall 12/22/14 Boston
West Coast Biotech Roundup: Intarcia, Dendreon, Amgen, Doudna & More 11/13/14 San Francisco
Servier Inks $1B Deal for Intarcia’s Implantable Diabetes Device 11/12/14 Boston
So Far, Little Proof That Digital Health Is Healthy. Does It Matter? 10/07/14 National
East Coast Biotech Roundup: Intarcia, Atlas, Visterra, & More 10/06/14 Boston
From Autism to Diabetes to HIPAA, Rock Health Seeds 8 More Startups 08/18/14 San Francisco
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
West Coast Biotech Roundup: Ligand, Ardelyx, Mango Health, and More 05/23/14 San Diego
Overstreet, Winner in Startup Tax Battle, Gets $2M for AdverseEvents 04/16/14 San Francisco
East Coast Biotech Roundup: Berg, Forma/Celgene, Intarcia, & More 04/04/14 Boston
Seattle’s KinDex Gets $5M to Fight Diabetes, Burn Fat With Hops 03/25/14 Seattle
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
Relypsa Aims to Delay Need for Costly Dialysis in Kidney Patients 02/05/14 San Francisco
PureTech Ventures, JDRF Team Up to Form Type 1 Diabetes Startup Creator 10/15/13 Boston
Array Biopharma Cuts Staff by 20%, Loses Development Deal with Amgen 08/07/13 Boulder/Denver
MI Biotech Roundup: Rockwell, Metabolic Solutions Publish New Data 07/18/13 Detroit Ann Arbor
Page 1 of 3 next page »